-
S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade
- 2022/04/11
- 再生時間: 23 分
- ポッドキャスト
-
サマリー
あらすじ・解説
In this episode, our faculty looks at the latest treatments for multiple sclerosis—the newest sphingosine-1-phosphate receptor modulators. What is their mechanism of action? Which patients would benefit from them, and how are side effects and toxicities managed with these latest treatment options?
Visit www.morningcommutepodcast.com/ms8 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit